Status:

ACTIVE_NOT_RECRUITING

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

Lead Sponsor:

University Teaching Hospital Hall in Tirol

Collaborating Sponsors:

Salzburger Landeskliniken

Conditions:

Urinary Bladder Neoplasm

Transitional Cell Carcinoma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Transurethral resection of bladder tumor (TURBT) is usually performed in a piecemeal technique. Tumor fragmentation and cell spilling could be responsible for high recurrence rates. Circulating tumor ...

Detailed Description

Bladder cancer is the 9th most commonly diagnosed cancer in men worldwide, with a standardized incidence rate of 9.0 per 100,000 person-years for men and 2.2 per 100,000 person-years for women. Amongs...

Eligibility Criteria

Inclusion

  • female and male patients
  • recurrent bladder tumor
  • preoperative cystoscopy
  • CT or MRI scan of abdomen not older than 30 days prior to surgery without suspicion of advanced disease (MIBC, metastasis)
  • max. non-invasive papillary tumor (pTa) staging in prior histology
  • max. low grade grading in prior histology
  • max. 5 lesions in actual cystoscopy (all \< 3cm)
  • exophytic tumors
  • transitional cell cancer of urinary bladder
  • patient able to give consent
  • signed consent form

Exclusion

  • initial tumor
  • flat lesion
  • \> 3cm
  • carcinoma in situ (CIS) in prior histology or suspicious CIS-finding in actual cystoscopy
  • high grade grading in prior histology
  • ≥ pT1 (tumor infiltration into subepithelial connective tissue) staging in prior histology
  • \> 5 lesions
  • different entity from transitional cell carcinoma of urinary bladder
  • prior radiation
  • emergency surgery
  • prior indwelling catheter (extraction \< 1 week prior to surgery)
  • pregnancy
  • orthotopic neobladder

Key Trial Info

Start Date :

March 14 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04811846

Start Date

March 14 2021

End Date

October 1 2025

Last Update

December 9 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

LKH Hall in Tirol, Department of Urology and Andrology

Hall in Tirol, Austria, 6060

2

LKH Salzburg, Department of Urology and Andrology

Salzburg, Austria, 5020

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood | DecenTrialz